Article Versions Notes

Schmidt RFM, Harder Y, Rossi L, Canino P, Schiaffino S, Calcinotto A, Perriard U, Graffeo R, Decio R, Canonica C, et al. Albumin-To-Alkaline Phosphatase Ratio as a New Early Predictive Marker of Axillary Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Pilot Study. Medicina. 2024; 60(11):1767. https://doi.org/10.3390/medicina60111767

Schmidt, Rahel Felicia Mirjam, Yves Harder, Lorenzo Rossi, Paola Canino, Simone Schiaffino, Arianna Calcinotto, Ulrike Perriard, Rossella Graffeo, Roberta Decio, Claudia Canonica, and et al. 2024. "Albumin-To-Alkaline Phosphatase Ratio as a New Early Predictive Marker of Axillary Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Pilot Study" Medicina 60, no. 11: 1767. https://doi.org/10.3390/medicina60111767

Schmidt, R. F. M., Harder, Y., Rossi, L., Canino, P., Schiaffino, S., Calcinotto, A., Perriard, U., Graffeo, R., Decio, R., Canonica, C., Cuzzocrea, M., Farooqi, A. A., Colombo, G. E., Diller, M., Peradze, N., Papadia, A., Pagnamenta, A., & Gasparri, M. L. (2024). Albumin-To-Alkaline Phosphatase Ratio as a New Early Predictive Marker of Axillary Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Pilot Study. Medicina, 60(11), 1767. https://doi.org/10.3390/medicina60111767